Is continuous long-term treatment with colchicine associated with lower rates of all-cause mortality and myocardial infarction and higher rates of adverse events?
Continuous long-term treatment with colchicine may be associated with lower rates of myocardial infarction, but may be associated with higher rates of gastrointestinal adverse events.
Lars G. Hemkens, Hannah Ewald, Matthias Briel. Colchicine and Prevention of Cardiovascular Events. JAMA. 2016;316(10):1106–1107. doi:10.1001/jama.2016.11044